DE3881373D1 - Hmg-coa-reduktase-hemmer. - Google Patents

Hmg-coa-reduktase-hemmer.

Info

Publication number
DE3881373D1
DE3881373D1 DE8888203032T DE3881373T DE3881373D1 DE 3881373 D1 DE3881373 D1 DE 3881373D1 DE 8888203032 T DE8888203032 T DE 8888203032T DE 3881373 T DE3881373 T DE 3881373T DE 3881373 D1 DE3881373 D1 DE 3881373D1
Authority
DE
Germany
Prior art keywords
coa reductase
reductase inhibitors
hmg coa
hmg
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888203032T
Other languages
English (en)
Inventor
William F Hoffman
Ta Jyh Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3881373D1 publication Critical patent/DE3881373D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888203032T 1988-01-07 1988-12-29 Hmg-coa-reduktase-hemmer. Expired - Lifetime DE3881373D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/142,377 US4857547A (en) 1988-01-07 1988-01-07 Novel HMG-CoA reductase inhibitors

Publications (1)

Publication Number Publication Date
DE3881373D1 true DE3881373D1 (de) 1993-07-01

Family

ID=22499617

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888203032T Expired - Lifetime DE3881373D1 (de) 1988-01-07 1988-12-29 Hmg-coa-reduktase-hemmer.

Country Status (5)

Country Link
US (1) US4857547A (de)
EP (1) EP0325817B1 (de)
JP (1) JPH02731A (de)
CA (1) CA1307265C (de)
DE (1) DE3881373D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36481E (en) * 1986-06-23 2000-01-04 Merck & Co., Inc. HMG-CoA reductase inhibitors
US5116870A (en) * 1986-06-23 1992-05-26 Merck & Co., Inc. HMG-CoA reductase inhibitors
US4940727A (en) * 1986-06-23 1990-07-10 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
CA2009043A1 (en) * 1989-02-01 1990-08-01 Michael J. Ferris Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives
US4950118A (en) * 1989-03-22 1990-08-21 Caterpillar Industrial Inc. System for loading and unloading trailers using automatic guided vehicles
US4970231A (en) * 1989-06-09 1990-11-13 Merck & Co., Inc. 4-substituted HMG-CoA reductase inhibitors
US5173487A (en) * 1989-11-13 1992-12-22 E. R. Squibb & Sons, Inc. Mevinic acid derivatives
US5112857A (en) * 1990-09-04 1992-05-12 Merck & Co., Inc. Hmg-coa reductase inhibitor metabolites
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
US6334226B1 (en) * 1997-10-22 2002-01-01 Toto Ltd. Faucet support member
US6002021A (en) * 1998-06-29 1999-12-14 Industrial Technology Research Institute Process for preparing 6(R)-{2-8'(S)-2",2"-dimethylbutyryloxy-2'(S)-6'(R)-dimethyl-1',2',6'7',8' 8'A(R)-hexahydronapthyl-1'(S)-ethyl}-4(R)-hydroxy-3,4,5,6-tetrahydro-2H- pyran-2-one
DE60031447T2 (de) * 1999-11-30 2007-08-30 Teva Gyogyszergyar Zartköruen Muködo Reszvenytarsasag Verfahren zur rückgewinnung von statinverbindungen aus einer fermentationsbrühe
SK8312002A3 (en) * 1999-12-14 2003-05-02 Biogal Gyogyszergyar Novel forms of pravastatin sodium
IL160077A0 (en) * 2001-08-16 2004-06-20 Teva Pharma Processes for preparing calcium salt forms of statins
WO2005051372A2 (en) * 2003-11-24 2005-06-09 Teva Gyógyszergyár Zártköruen Muködo Részvénytársaság Method of purifying pravastatin
TW200640854A (en) * 2005-02-09 2006-12-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of making pravastatin sodium
WO2007020079A2 (en) * 2005-08-17 2007-02-22 Synthon B.V. Orally disintegratable simvastatin tablets
US10736871B2 (en) 2015-04-01 2020-08-11 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
EP0245004A3 (de) * 1986-05-05 1989-07-26 Merck & Co. Inc. Antihypercholesterolemische Verbindungen
EP0245990A3 (de) * 1986-05-05 1989-07-19 Merck & Co. Inc. Antihypercholesterolemische Verbindungen
US4661483A (en) * 1986-05-05 1987-04-28 Merck & Co., Inc. Antihypercholesterolemic lactone compounds, compositions and use
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
EP0325817A1 (de) 1989-08-02
EP0325817B1 (de) 1993-05-26
CA1307265C (en) 1992-09-08
JPH02731A (ja) 1990-01-05
US4857547A (en) 1989-08-15

Similar Documents

Publication Publication Date Title
DE3681991D1 (de) Hmg-coa-reduktase-hemmungskoerper.
DE3770345D1 (de) Inhibitoren von hmg-coa-reduktase.
DE68904083D1 (de) Hmg-coa-reduktaseinhibitoren.
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE3864608D1 (de) Hmg-coa-reduktasehemmer.
NO942064D0 (no) yminhibitorer
DE68924832D1 (de) Metallischer dichtungsring.
DE3881373D1 (de) Hmg-coa-reduktase-hemmer.
FI904729A0 (fi) Inhibitorer av retrovirala proteaser.
DE68901091D1 (de) Hmg-coa-reduktaseinhibitoren.
MX9203768A (es) Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a.
NO904463D0 (no) Korrosjonsinhibitor.
DE68900988D1 (de) Hmg-coa-reduktase-inhibitoren.
DE69001146D1 (de) Koenzym q10 mit hmg-coa-reduktase-inhibitoren.
DE69020394D1 (de) Aldose-Reductase-Inhibitor.
DE69401748D1 (de) Ladepalette
DE69008277D1 (de) 7-Subsituierte HMG-CoA-Reduktase-Inhibitoren.
DK123890D0 (da) Fremgangsmaade til sporspring
DK519289A (da) Mikrobiel reduktase
DE3869282D1 (de) Inhibitoren von hmg-coa-reduktase.
DE58901402D1 (de) Metallische flachdichtung.
DE9312615U1 (de) Datenträger
IE882653L (en) HMG CoA REDUCTASE INHIBITORS
IE862071L (en) HMG CoA REDUCTASE INHIBITORS
NO923862L (no) Inhibitorer for hmg-coa-reduktase

Legal Events

Date Code Title Description
8332 No legal effect for de